Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1367316 | Bioorganic & Medicinal Chemistry Letters | 2006 | 4 Pages |
Abstract
X-Linked inhibitor of apoptosis protein (XIAP) is a promising molecular target for the design of new anticancer drugs aiming at promoting apoptosis in cancer cells. We have previously identified embelin as an inhibitor of XIAP through computational structure-based database screening. Herein, we report the design, synthesis, and evaluation of new embelin analogues as inhibitors of XIAP. Our efforts led to the identification of new and more potent inhibitors. For example, compound 6g has a Ki value of 180 nM binding to XIAP BIR3, in a competitive binding assay and represents a promising lead compound for further optimization.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jianyong Chen, Zaneta Nikolovska-Coleska, Guoping Wang, Su Qiu, Shaomeng Wang,